All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Thiazolidinone-based compounds as dual-purpose therapeutics: antimicrobial efficacy, cytotoxicity and pharmacokinetic potential

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F25%3A73635354" target="_blank" >RIV/61989592:15110/25:73635354 - isvavai.cz</a>

  • Result on the web

    <a href="https://journals.uran.ua/sr_pharm/article/view/342467" target="_blank" >https://journals.uran.ua/sr_pharm/article/view/342467</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.15587/2519-4852.2025.342467" target="_blank" >10.15587/2519-4852.2025.342467</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Thiazolidinone-based compounds as dual-purpose therapeutics: antimicrobial efficacy, cytotoxicity and pharmacokinetic potential

  • Original language description

    Infectious diseases and cancer remain leading global health challenges, with rising resistance to existing antibiotics and limited selectivity of many cytotoxic agents. Heterocyclic scaffolds, particularly thiazolidinones, offer a promising platform for the development of novel antimicrobial and anticancer compounds. The aim of the study. To evaluate the antimicrobial and cytotoxic properties of thiazolidinone-based compounds against a panel of pathogenic microorganisms and human cancer cell lines, and to identify the most promising derivatives with favorable safety, pharmacokinetic, and mechanistic profiles through molecular docking and dynamics studies. Materials and methods. A library of 5-enamine(hydrazine)-4-thiazolidinone derivatives was screened for antimi-crobial activity against Gram-positive and Gram-negative bacteria and Candida albicans, and for cytotoxic activity against six human cancer cell lines. Minimum inhibitory concentrations (MIC) were determined, and IC50 values were measured for selected compounds. Pharmacokinetic properties, including gastrointestinal absorption and li-pophilicity, were assessed in silico. To investigate potential mechanisms of antibacterial action, molecular docking was performed against MurB

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database

  • CEP classification

  • OECD FORD branch

    10608 - Biochemistry and molecular biology

Result continuities

  • Project

    <a href="/en/project/LX22NPO5103" target="_blank" >LX22NPO5103: National Institute of Virology and Bacteriology</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    ScienceRise: Pharmaceutical Science

  • ISSN

    2519-4844

  • e-ISSN

    2519-4852

  • Volume of the periodical

    5

  • Issue of the periodical within the volume

    57

  • Country of publishing house

    UA - UKRAINE

  • Number of pages

    14

  • Pages from-to

    88-101

  • UT code for WoS article

  • EID of the result in the Scopus database

    2-s2.0-105022489828